Combination therapy consisting of gemcitabine, docetaxel and carboplatin as a second-line chemotherapy for patients with MVAC-treated metastatic urothelial carcinoma

Combination therapy consisting of gemcitabine, docetaxel and carboplatin as a second-line chemotherapy for patients with MVAC-treated metastatic urothelial carcinoma

From 2001 to 2006, 11 patients with MVAC-treated metastatic urothelial carcinoma received as a second-line therapy GDC therapy consisting of gemcitabine (1,000 mg/m2) on day land 8, docetaxel (80 mg/m2) on day 1 and carboplatin (AUC 5) on day 1 in each 21-day cycle. The 11 patients received a total...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 54(2008), 9 vom: 23. Sept., Seite 581-5
1. Verfasser: Inoue, Takamitsu (VerfasserIn)
Weitere Verfasser: Obara, Takashi, Saito, Mitsuru, Kumazawa, Teruaki, Narita, Shintaro, Horikawa, Yohei, Yuasa, Takeshi, Tsuchiya, Norihiko, Satoh, Shigeru, Habuchi, Tomonori
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 2008
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Journal Article Taxoids Deoxycytidine 0W860991D6 Docetaxel 15H5577CQD Vinblastine 5V9KLZ54CY Doxorubicin 80168379AG mehr... Carboplatin BG3F62OND5 Cisplatin Q20Q21Q62J Methotrexate YL5FZ2Y5U1 Gemcitabine